Surfactant-polymer nanoparticles: A novel platform for sustained and enhanced cellular delivery of water-soluble molecules

Pharmaceutical Research

Volumn 24, Issue 4, 2007, Pages 803-810

  Chavanpatil, Mahesh D ^a   Khdair, Ayman ^a   Panyam, Jayanth ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Cellular drug delivery; Cytotoxicity; Endocytosis; Exocytosis; Sustained release

Indexed keywords

DOCUSATE SODIUM ALGINIC ACID NANOPARTICLE; DOXORUBICIN; DRUG CARRIER; RHODAMINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOSE TIME EFFECT RELATION; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG RETENTION; DRUG SOLUTION; DRUG UPTAKE; EMULSION; HUMAN; HUMAN CELL; IN VITRO STUDY; NANOENCAPSULATION; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

ALGINATES; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL MEMBRANE; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DIOCTYL SULFOSUCCINIC ACID; DOXORUBICIN; DRUG CARRIERS; DRUG COMPOUNDING; EXOCYTOSIS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; KINETICS; MOLECULAR WEIGHT; NANOPARTICLES; PARTICLE SIZE; POLYMERS; RHODAMINES; SOLUBILITY; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS; WATER;

EID: 33947143588     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9203-2     Document Type: Article

References (40)

1. M. Binaschi, M. Bigioni, A. Cipollone, C. Rossi, C. Goso, C. A. Maggi, G. Capranico, and F. Animati. Anthracyclines: selected new developments. Curr. Med. Chem. Anti-Canc. Agents 1:113-130 (2001).
2. J. Zhao, J. E. Kim, E. Reed, and Q. Q. Li. Molecular mechanism of antitumor activity of taxanes in lung cancer (Review). Int. J. Oncol. 27:247-256 (2005).
3. I. M. Adcock and K. Ito. Glucocorticoid pathways in chronic obstructive pulmonary disease therapy. Proc. Am. Thorac. Soc. 2:313-319 (2005).
4. J. E. Dancey. mTOR inhibitors in hematologic malignancies. Clin. Adv. Hematol. Oncol. 1:419-423 (2003).
5. J. Panyam and V. Labhasetwar. Targeting intracellular targets. Curr. Drug Deliv. 1:235-247 (2004).
6. J. Panyam and V. Labhasetwar. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55:329-347 (2003).
7. A. Martin, P. Bustamante, and A. H. C. Chun. Physical pharmacy. Physical chemical principles in the pharmaceutical sciences. Waverly International, Baltimore, 1993.
8. M. R. Franklin and D. N. Franz. Drug absorption, action, and disposition. In P. Beringer, A. DerMarderosian, L. Felton, S. Gelone, A. R. Gennaro, P. Gupta, J. E. Hoover, N. G. Popovick, W. J. Reilly, and R. Hendrickson (eds.), Remington: The Science and Practice of Pharmacy, Lippincott Williams and Wilkins, Philadelphia, 2000, pp. 1142-1170.
9. J. Panyam and V. Labhasetwar. Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. Mol. Pharm. 1:77-84 (2004).
10. H. Suh, B. Jeong, R. Rathi, and S. W. Kim. Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly (ethylene oxide)-poly(lactide/ glycolide) nanospheres. J. Biomed. Mater. Res. 42:331-338 (1998).
11. M. O. Oyewumi and R. J. Mumper. Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles. Int. J. Pharm. 251:85-97 (2003).
12. M. G. Cascone, L. Lazzeri, C. Carmignani, and Z. Zhu. Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexate. J. Mater. Sci. Mater. Med. 13:523-526 (2002).
13. Y. Ueno, H. Futagawa, Y. Takagi, A. Ueno, and Y. Mizushima. Drug-incorporating calcium carbonate nanoparticles for a new delivery system. J. Control. Release 103:93-98 (2005).
14. J. Vandervoort and A. Ludwig. Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use. Eur. J. Pharm. Biopharm. 57:251-261 (2004).
15. Y.M. Yi, T. Y. Yang, and W. M. Pan. Preparation and distribution of 5-fluorouracil (125)I sodium alginate-bovine serum albumin nanoparticles. World J. Gastroenterol. 5:57-60 (1999).
16. M. Chavanpatil, A. Khdair, Y. Patil, H. Handa, M. Guangzhao and J. Panyam. Polymer-surfactant nanoparticles for sustained release of water-soluble drugs. J Pharm Sci (in press) (2006).
17. R. M. Iskakov, A. Kikuchi, and T. Okano. Time-programmed pulsatile release of dextran from calcium-alginate gel beads coated with carboxy-n-propylacrylamide copolymers. J. Control. Release 80:57-68 (2002).
18. T. Shimizu, M. Yamato, A. Kikuchi, and T. Okano. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials 24:2309-2316 (2003).
19. S. S. D'Souza and P. P. DeLuca. Development of a dialysis in vitro release method for biodegradable microspheres. AAPS PharmSciTech 6:E323-E328 (2005).
20. S. S. D'Souza and P. P. DeLuca. Methods to assess in vitro drug release from injectable polymeric particulate systems. Pharm. Res. 23:460-474 (2006).
21. J. Panyam and V. Labhasetwar. Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm. Res. 20:212-220 (2003).
22. S. K. Sahoo and V. Labhasetwar. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol. Pharm. 2:373-383 (2005).
23. M. P. Desai, V. Labhasetwar, G. L. Amidon, and R. J. Levy. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res. 13:1838-1845 (1996).
24. M. P. Desai, V. Labhasetwar, E. Walter, R. J. Levy, and G. L. Amidon. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. 14:1568-1573 (1997).
25. S. K. Sahoo, J. Panyam, S. Prabha, and V. Labhasetwar. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Control. Release 82:105-114 (2002).
26. S. De and D. Robinson. Polymer relationships during preparation of chitosan-alginate and poly-l-lysine-alginate nanospheres. J. Control. Release 89:101-112 (2003).
27. F. Némati, C. Dubernet, H. Fessi, A. Colin de Verdière, M. F. Poupon, F. Puisieux, and P. Couvreur. Reversion of multidrug resistance using nanoparticles in vitro: influence of the nature of the polymer. Int. J. Pharm. 138:237-246 (1996).
28. J. Israelachevilli. Intermolecular and Surface Forces, Academic, London, 1991.
29. I. Brigger, J. Morizet, L. Laudani, G. Aubert, M. Appel, V. Velasco, M. J. Terrier-Lacombe, D. Desmaele, J. d'Angelo, P. Couvreur, and G. Vassal. Negative preclinical results with stealth nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model. J. Control. Release. 100:29-40 (2004).
30. J. M. Scholtz. Antineoplastic drugs. In P. Beringer, A. DerMarderosian, L. Felton, S. Gelone, A. R. Gennaro, P. Gupta, J. E. Hoover, N. G. Popovick, W. J. Reilly, and R. Hendrickson (eds.), Remington: The Science and Practice of Pharmacy, Lippincott Williams and Wilkins, Philadelphia, 2000, pp. 1556-1587.
31. J. Panyam, W. Z. Zhou, S. Prabha, S. K. Sahoo, and V. Labhasetwar. Rapid endo-lysosomal escape of poly (DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. Faseb J.16:1217-1226 (2002).
32. S. Mukherjee, R. N. Ghosh, and F. R. Maxfield. Endocytosis. Physiol. Rev. 77:759-803 (1997).
33. M. Colin, M. Maurice, G. Trugnan, M. Kornprobst, R. P. Harbottle, A. Knight, R. G. Cooper, A. D. Miller, J. Capeau, C. Coutelle, and M. C. Brahimi-Horn. Cell delivery, intracellular trafficking and expression of an integrin-mediated gene transfer vector in tracheal epithelial cells. Gene Ther. 7:139-152 (2000).
34. T. J. Greenwalt. The how and why of exocytic vesicles. Transfusion 46:143-152 (2006).
35. J. A. Pickett and J. M. Edwardson. Compound exocytosis: mechanisms and functional significance. Traffic 7:109-116 (2006).
36. J. Gruenberg. The endocytic pathway: a mosaic of domains. Nat. Rev. Mol. Cell Biol. 2:721-730 (2001).
37. L. Serpe, M. Guido, R. Canaparo, E. Muntoni, R. Cavalli, P. Panzanelli, C. Della Pepal, A. Bargoni, A. Mauro, M. R. Gasco, M. Eandi, and G. P. Zara. Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell lines. J. Nanosci. Nanotechnol. 6:3062-3069 (2006).
38. L. Serpe, M. G. Catalano, R. Cavalli, E. Ugazio, O. Bosco, R. Canaparo, E. Muntoni, R. Frairia, M. R. Gasco, M. Eandi, and G. P. Zara. Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line. Eur. J. Pharm. Biopharm. 58:673-680 (2004).
39. A. Miglietta, R. Cavalli, C. Bocca, L. Gabriel, and M. R. Gasco. Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel. Int. J. Pharm. 210:61-67 (2000).
40. H. L. Wong, A. M. Rauth, R. Bendayan, J. L. Manias, M. Ramaswamy, Z. Liu, S. Z. Erhan, and X. Y. Wu. A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells. Pharm. Res. 23:1574-1585 (2006).